Genetic engineering in the context of medical applications and pharmaceutical research is an extremely wide-ranging field. We can only work on specific cases. For example, we are trying to stop patents on the use of human embryos in the production of stem cells. According to European patent law, such patent claims violate ethical principles. We also follow the discussions on interventions in the human germline and the increasing number of experiments with genetically engineered animals.